FUZION: A Phase 3, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Guselkumab in Participants with Fistulizing, Perianal Crohn#s Disease

Grants and Contracts Details

StatusActive
Effective start/end date11/17/238/24/28

Funding

  • Janssen Research and Development LLC: $2.00